 INDIANAPOLIS, Feb. 17, 2022 GLOBE NEWSWIRE -- POINT Biopharma Global Inc. NASDAQ: PNT the Company or POINT, a company accelerating the discovery, development and global access to life-changing radiopharmaceuticals, today announced that the Companys Chief Executive Officer, Dr. Joe McCann will participate in the following upcoming investor conferences. 